STRENSIQ

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 25682-019
  • Package NDC 25682-019-12
  • Application number BLA125513
  • SPL ID 404d99e5-991e-4353-bb9f-29dfa00a43b3
  • SPL set ID 3387574f-5eaa-4501-a71d-4cbfbd563031
  • UNII Z633861EIM
  • RxCUI 1720263
  • RxCUI 1720268
  • RxCUI 1720271
  • RxCUI 1720272
  • RxCUI 1720275
  • RxCUI 1720276
  • RxCUI 1720278
  • RxCUI 1720280

What the source publishes

Labeler
Alexion Pharmaceuticals, Inc.
Active ingredients
ASFOTASE ALFA
Form
SOLUTION
Routes
SUBCUTANEOUS
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:25682-019_404d99e5-991e-4353-bb9f-29dfa00a43b3
{
  "name": "STRENSIQ",
  "splId": "404d99e5-991e-4353-bb9f-29dfa00a43b3",
  "labels": [
    {
      "setId": "3387574f-5eaa-4501-a71d-4cbfbd563031",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3387574f-5eaa-4501-a71d-4cbfbd563031",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=3387574f-5eaa-4501-a71d-4cbfbd563031"
    }
  ],
  "routes": [
    "SUBCUTANEOUS"
  ],
  "labeler": "Alexion Pharmaceuticals, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "12 VIAL in 1 CARTON (25682-019-12)  / .8 mL in 1 VIAL (25682-019-01)",
      "package_ndc": "25682-019-12",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20151023"
    }
  ],
  "productId": "25682-019_404d99e5-991e-4353-bb9f-29dfa00a43b3",
  "useDomain": "unknown",
  "dosageForm": "SOLUTION",
  "productNdc": "25682-019",
  "deaSchedule": null,
  "genericName": "ASFOTASE ALFA",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ASFOTASE ALFA",
      "strength": "80 mg/.8mL"
    }
  ],
  "applicationNumber": "BLA125513",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20151023",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000191865",
      "M0000712"
    ],
    "unii": [
      "Z633861EIM"
    ],
    "rxcui": [
      "1720263",
      "1720268",
      "1720271",
      "1720272",
      "1720275",
      "1720276",
      "1720278",
      "1720280"
    ],
    "spl_set_id": [
      "3387574f-5eaa-4501-a71d-4cbfbd563031"
    ],
    "pharm_class_cs": [
      "Alkaline Phosphatase [CS]"
    ],
    "pharm_class_epc": [
      "Tissue-nonspecific Alkaline Phosphatase [EPC]"
    ],
    "manufacturer_name": [
      "Alexion Pharmaceuticals, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:25682-019_404d99e5-991e-4353-bb9f-29dfa00a43b3"